Cecilia Guzmán

Phase I and Pharmacokinetic Study of Aplidine, a New Marine Cyclodepsipeptide in Patients With Advanced Malignancies

Sandrine Faivre, Stéphanie Chièze, Catherine Delbaldo et al. · Journal of Clinical Oncology · 2005 · 99 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma

Caroline Laverdière, E. Anders Kolb, Jeffrey G. Supko et al. · Cancer · 2003 · 98 citations

Medicine, Oncology, Pharmacokinetics +15

A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignancies.

Miguel A. Villalona‐Calero, S. Gail Eckhardt, Geoffrey R. Weiss et al. · PubMed · 2002 · 82 citations

Medicine, Oncology, Pharmacology +15

Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens

José Alejandro Pérez Fidalgo, Susana Roselló, Elisa García-Garré et al. · Breast Cancer Research and Treatment · 2009 · 65 citations · Full text

Medicine, Oncology, Pharmacology +14

Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity

Thomas A. Puchalski, David P. Ryan, Rocio García‐Carbonero et al. · Cancer Chemotherapy and Pharmacology · 2002 · 63 citations

Medicine, Pharmacokinetics, Pharmacology +14